Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000104

Director sold 1,666 shares at $18.29 ($30,471)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SATO VICKI L Director 2024-04-15 Sale 10b5-1 −1,666 $18.29 $30,471 118,043 D
Open-market sales · 1,666 sh · avg $18.29 · $30,471
Loading xslF345X05/wk-form4_1713388471.xml…